title: [Can intensive induction chemotherapy eradicate retroperitoneal lymph node metastases in children over 1 year of age with stage 4 neuroblastoma?].
abstract: The prognosis in patients over 1 year of age with stage 4 neuroblastoma (NBL) is poor in spite of intensive treatment. The choice of intensive chemotherapy and extension of the surgery, especially in the case when the tumor is localized in the abdomen, is still controversial. Between 1991-2001 there were 61 patients with NBL treated in our Department; 28 of them were older than 1 year and had stage 4 with the tumor localized in the abdomen. All children received intensive chemotherapy according to Japanese protocol. Three children with disease progression during intensive treatment where excluded from further analysis. In 22 children with good or very good response to chemotherapy, the surgery was performed. In 4 patients it was local surgery. In 18 patients the tumor was removed with all visible retroperitoneal lymph nodes (so called Tsuchida surgery). The histopathological evaluation was performed in 17 patients with Tsuchida surgery and in 13 cases metastases in retroperitoneal lymph nodes were found. The 5-year overall survival was significantly better in the group with Tsuchida surgery performed (0.66 vs 0.21, p=0.044) for the patients in stage 4. After the intensive induction of chemotherapy the metastases in retroperitoneal lymph nodes can still be found. The removal of the tumor with all retroperitoneal lymph nodes can improve treatment results in patients with advanced abdominal neuroblastoma, but it is necessary to investigate more patients and to prolong the observation period.
authors.affiliation: Klinika Onkologii i Hematologii Dzieciecej, Polsko-Amerykański Instytutu Pediatrii, Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie.
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Niezgoda
authors.forename: Walentyna
authors.initials: W
authors.lastname: Balwierz
authors.forename: Adam
authors.initials: A
authors.lastname: Bysiek
authors.forename: Witold
authors.initials: W
authors.lastname: Miezyński
authors.forename: Tomasz
authors.initials: T
authors.lastname: Klekawka
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Garus
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002675:Child, Preschool; D018572:Disease-Free Survival; D005260:Female; D005784:Gene Amplification; D016259:Genes, myc; D006801:Humans; D007223:Infant; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery*; D011044:Poland; D011379:Prognosis; D012044:Regression Analysis; D012074:Remission Induction; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery*; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D016896:Treatment Outcome